Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly valuable in the development of central nervous system (CNS) drugs, where its structural properties contribute to the modulation of neurotransmitter activity. Additionally, it finds application in the creation of compounds targeting neurological disorders, such as depression, anxiety, and chronic pain. Its trifluoromethoxy group enhances its binding affinity to specific receptors, making it a crucial component in drug discovery and development processes.